Studying the signaling pathways affected by the heterozygous loss of FOXA2, as well as identifying the upstream and downstream protein partners of FOXA2, may allow an understanding of how FOXA2 haploinsufficiency leads to GH deficiency and hypopituitarism. The gene discussed is FOXA2; the disease is hypopituitarism.